Japan’s basic pharmaceutical products and pharmaceutical preparations exports to Indonesia have shown fluctuating trends from 2013 to 2023, with a notable decline over the past decade. In 2023, the export value stood at 32.436 million US dollars, reflecting a 0.71% year-on-year decrease. Over the last two years, the average decline was about 5.225%. The Compound Annual Growth Rate (CAGR) over the past five years was approximately -0.99%. Moving forward, the exports are forecasted to continue a slight decline with a CAGR of -0.59% over the next five years, ending at about 31.514 million US dollars by 2028.

Future trends to watch for:

Increased competition from other pharmaceutical exporters could further impact Japan’s market share in Indonesia.
Changes in regulatory policies in both Japan and Indonesia could influence future export volumes.
Innovation and development in pharmaceutical products may open new opportunities for export growth.